| Home | E-Submission | Sitemap | Editorial Office
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim
Clin Mol Hepatol.2017;23(1):66-73.   Published online February 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0060
                              
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                              
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.2016;22(2):286-291.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0066
                                 Cited By 1
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.2016;22(2):241-249.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0053
                                 Cited By 1
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol.2016;22(2):238-240.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0103
                              
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol.2016;22(1):152-159.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.152
                              
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol.2015;21(3):242-248.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.242
                                 Cited By 1
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
Clin Mol Hepatol.2015;21(1):41-48.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.41
                                 Cited By 5
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Clin Mol Hepatol.2014;20(3):261-266.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.261
                                 Cited By 4
1 |
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.